-The Times of India MUMBAI: Some multinational companies (MNCs) have been delaying the launch of life-saving drugs in India years after getting monopoly rights, while cheaper generic versions of exorbitantly-priced medicines are going off the shelves under the product patenting law. Corporates such as Japanese firm Otsuka Pharmaceuticals, US-based Bristol Myers-Squibb (BMS) and Swiss firm Novartis are deferring the launch of medicines critical for treatment of serious non-communicable diseases like cancer, HIV,...
More »SEARCH RESULT
Total Matching Records found : 113
India’s 11% of neonatal deaths happen in Bihar -Banjot Kaur Bhatia
-The Times of India PATNA: Though Bihar has witnessed a steady decline in neonatal mortality rate (NMR) in recent years, it accounts for second highest total number of neonatal deaths in India. With NMR at 28, the state accounts for 11 per cent neonatal deaths in the country. NMR is defined as death of infants (within one month of birth) per 1,000 live births. Incidentally, every year around 30 lakh live births...
More »Made for Big Pharma -Paranjoy Guha Thakurta
-Deccan Chronicle Prime Minister Narendra Modi may be patting himself on the back because President Barack Obama has agreed to India's position on food stockholding norms in World Trade Organisation (WTO). However, New Delhi seems to be bending over backwards to accommodate the American government and giant multinational corporations (MNCs) in the pharmaceutical industry, which will work to the detriment of our country's interests. In less than six months, the Modi government...
More »From January 2015, life-saving drugs to show govt-fixed rates in bold red -Sushmi Dey
-The Times of India NEW DELHI: All Life Saving Drugs from January 2015 will come with a bold red strip on their packs highlighting price as fixed by the government and also specify if they are under price control. Signaling a New Year gift for consumers, the government is set to make it mandatory for regulated drugs to print on their packs 'DPCO Scheduled Drug' in black ink on a bold...
More »Top-selling 100 drugs to get cheaper soon -Sushmi Dey
-The Times of India NEW DELHI: Top selling medicine brands for stress, hypertension, HIV, pain and pneumonia may soon become cheaper. The drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to bring in at least 100 new drugs under price control to include combinations, dosages and strengths that are commonly prescribed by doctors and sold by pharmacists. For instance, currently only one strength of Paracetamol is under price control, whereas...
More »
